Anti-HIV1 gp120 Neutralizing Antibody (V3S-0522-YC173) (CAT#: V3S-0522-YC173)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Sub Cat Epitope Isotype Application  
V3S-1124-YC873 IgG Neut Inquiry
V3S-0522-YC174 IgG WB; Neut Inquiry
V3S-0522-YC3395 IgG1 kappa ELISA; WB; Neut Inquiry
V3S-0522-YC574 IgG ELISA; Neut Inquiry
V3S-0522-YC7405 IgG3 lambda WB; ELISA; Neut; FuncS Inquiry
V3S-0522-YC7408 IgG WB; ELISA; Neut; FuncS Inquiry
V3S-0522-YC7409 IgG WB; Neut; FuncS Inquiry
V3S-0522-YC7600 IgG kappa WB; ELISA; Neut; FuncS Inquiry
V3S-0522-YC7717 IgG Neut; ELISA Inquiry
V3S-0522-YC7728 IgG ELISA; Neut; FuncS Inquiry
V3S-0522-YC7731 IgG3 lambda Neut; ELISA Inquiry
V3S-0522-YC7733 IgG1 lambda Neut Inquiry
V3S-0522-YC7734 IgG ELISA; Neut; WB; IF; FuncS Inquiry
V3S-0522-YC7740 IgG ELISA; Neut Inquiry
V3S-0522-YC7743 IgG WB; IF; Neut; FuncS Inquiry
V3S-0522-YC8042 IgG FC; Neut Inquiry
V3S-0522-YC8052 IgG1 lambda ELISA; Neut Inquiry
V3S-0522-YC8142 IgG WB; ELISA; Neut Inquiry
V3S-0522-YC8144 IgG WB; ELISA; Neut Inquiry
V3S-0522-YC8264 IgG2 kappa Neut Inquiry
V3S-0522-YC8340 IgG Neut Inquiry
V3S-0522-YC8357 IgG WB; ELISA; Neut Inquiry
V3S-0723-XY20 N276 glycan-dependent epitope ELISA; Neut Inquiry
V3S-0723-XY23 In the CD4-binding site. ELISA; BLI Inquiry
V3S-0723-XY24 In the CD4-binding site ELISA; Neut; BLI Inquiry
V3S-0522-YC7403 IgG1 WB; ELISA; FuncS Inquiry
V3S-0522-YC7410 IgG WB; ELISA; IF; FuncS Inquiry
V3S-0522-YC7726 IgG WB; IHC; IF; FuncS Inquiry
V3S-0522-YC7739 IgG WB; ELISA; IF; FuncS Inquiry
V3S-0723-FY69 IgG ELISA; FuncS Inquiry
V3S-1022-YC1611 IgG WB Inquiry
Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Human immunodeficiency virus type 1 Envelope glycoprotein GP120. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human immunodeficiency virus 1 (HIV1)
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application Neut
Application Notes The antibody is recommended for detection of HIV1 gp120 by Neut assay.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target HIV1 gp120
Alternative Name Human immunodeficiency virus type 1; HIV1; Envelope glycoprotein GP120; gp120; HIV envelope
Gene ID 155971
UniProt P04578
Research Area Infectious Disease
Related Disease HIV1 infection
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry